Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced/Metastasis Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00121251
What this trial is testing

Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer

Who this might be right for
Recurrent Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7Stage IV Renal Cell Cancer AJCC v7
National Cancer Institute (NCI) 17
Large-scale testing (Phase 3)Active Not RecruitingNCT05522231
What this trial is testing

Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2)

Who this might be right for
Advanced Renal Cell Carcinoma
Hutchmed 265
Testing effectiveness (Phase 2)Ended earlyNCT00004856
What this trial is testing

Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium

Who this might be right for
Distal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterProximal Urethral Cancer+6 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)WithdrawnNCT05176288
What this trial is testing

Avelumab, Palbociclib and Axitinib in Advanced RCC

Who this might be right for
Advanced Clear Cell Renal Cell Carcinoma
Bradley A. McGregor, MD
Large-scale testing (Phase 3)Study completedNCT01613846
What this trial is testing

Phase III Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma (SWITCH-II)

Who this might be right for
Renal Cell Carcinoma
Technical University of Munich 544
Testing effectiveness (Phase 2)Study completedNCT02599324
What this trial is testing

Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors

Who this might be right for
Metastatic Renal Cell CarcinomaAdvanced Urothelial CarcinomaAdvanced Gastric Adenocarcinoma+1 more
Pharmacyclics LLC. 263
Early research (Phase 1)Looking for participantsNCT05092373
What this trial is testing

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Who this might be right for
Advanced Breast CarcinomaAdvanced Endometrial CarcinomaAdvanced Fallopian Tube Carcinoma+71 more
M.D. Anderson Cancer Center 43
Testing effectiveness (Phase 2)Study completedNCT00003175
What this trial is testing

Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Medical Research Council 45
Not applicableStudy completedNCT01026337
What this trial is testing

Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Renal Cell CarcinomaStage III Renal Cell CancerStage IV Renal Cell Cancer
Abramson Cancer Center at Penn Medicine 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT04848519
What this trial is testing

Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+11 more
Emory University 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT03237780
What this trial is testing

Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+21 more
National Cancer Institute (NCI) 72
Not applicableStudy completedNCT02940639
What this trial is testing

Real-Life Effectiveness and Safety in Participants With Advanced/Metastatic Renal Cell Carcinoma Starting 1st Line Nivolumab and Ipilimumab Combination Therapy or Nivolumab Monotherapy After Prior Therapy

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 499
Testing effectiveness (Phase 2)Looking for participantsNCT07410676
What this trial is testing

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Who this might be right for
CancerSarcomaLeukaemia+12 more
Essen Biotech 83
Early research (Phase 1)Active Not RecruitingNCT02974738
What this trial is testing

A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)

Who this might be right for
Advanced Solid TumorsSolid TumorSolid Carcinoma+13 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 120
Post-approval studies (Phase 4)Study completedNCT01521715
What this trial is testing

First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Locally Advanced and/or Metastatic Renal Cell CarcinomaCarcinoma, Renal CellClear-cell Metastatic Renal Cell Carcinoma
iOMEDICO AG 44
Testing effectiveness (Phase 2)WithdrawnNCT03598816
What this trial is testing

PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Washington University School of Medicine
Not applicableStudy completedNCT01107509
What this trial is testing

Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of Biomarkers

Who this might be right for
Carcinoma, Renal Cell
St. Joseph's Healthcare Hamilton 20
Early research (Phase 1)Study completedNCT03829111
What this trial is testing

CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer

Who this might be right for
Advanced Renal Cell CarcinomaClear Cell Renal Cell CarcinomaMetastatic Renal Cell Carcinoma+3 more
City of Hope Medical Center 30
Testing effectiveness (Phase 2)UnknownNCT00030888
What this trial is testing

UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of California, San Francisco
Early research (Phase 1)Looking for participantsNCT06465069
What this trial is testing

LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 420
Next Page